Shingles vaccine study for young adult transplant recipients
Treatments studied
Part of Cancer, Infections clinical trials.
This study tests the shingles vaccine in young adults who have had a solid organ transplant (like a kidney or liver) more than a year ago. The goal is to see if the vaccine works well and is safe for people on stable anti-rejection medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You received a solid organ transplant (like kidney, liver, heart, or lung) at least one year ago.
- Your anti-rejection medication has been stable (no major changes) for the past 6 months.
- You are willing to use effective birth control if you could become pregnant, until 2 months after the last vaccine dose.
- You have not had shingles, chickenpox, or the shingles vaccine in the past year.
- You are not currently being treated for transplant rejection with high-dose steroids or other strong medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study looks at how well the shingles vaccine works in people who had an allogeneic (donor) stem cell transplant. It aims to measure the body’s immune response to the vaccine and check that it’s safe in this recovery period.
This trial tests whether the shingles vaccine (RZV) is safe and works well for organ transplant recipients and their household members. It also includes people on dialysis or certain immunosuppressants.
This study tests whether an investigational shingles (herpes zoster) vaccine is safe and helps prevent shingles in children who have had a kidney transplant. Because these children take medicines to prevent rejection, the study specifically looks at vaccine effects in this higher-risk group.
This trial tests a new shingles vaccine for healthy adults 40 and older. It aims to see if the vaccine is safe and helps protect against shingles.
This trial tests an experimental vaccine designed to prevent shingles (a painful rash caused by the varicella-zoster virus). It will help see if the vaccine is safe and triggers a good immune response in adults 40 and older.
This study tests whether an extra dose of the Shingrix shingles vaccine can boost your protection against shingles after an organ transplant. It may help you stay healthier by strengthening your immune system's defenses.
Hear when a new Varicella Zoster trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.